Evidence map›Paper›PMID 22363466›Full record

ArticlePloS one2012

Lysine residue at position 22 of the AID protein regulates its class switch activity.

Roland Geisberger, Michael Huemer, Franz J Gassner, Nadja Zaborsky, Alexander Egle, Richard Greil

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Insights on SNPs of Human Activation-Induced Cytidine Deaminase AID.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Roland GeisbergerLaboratory for Immunological and Molecular Cancer Research, IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Paracelsus Medical University Salzburg, Salzburg, Austria. r.geisberger@salk.at
Michael Huemer
Franz J Gassner
Nadja Zaborsky
Alexander Egle
Richard Greil
Paracelsus Medical University · AT

Funding

Austrian Science Fund FWF T 516
6 · The paper itself

Abstract

backgroundActivation induced deaminase (AID) mediates class switch recombination and somatic hypermutation of immunoglobulin (Ig) genes in germinal centre B cells. In order to regulate its specific activity and as a means to keep off-target mutations low, several mechanisms have evolved, including binding to specific cofactors, phosphorylation and destabilization of nuclear AID protein. Although ubiquitination at lysine residues of AID is recognized as an essential step in initiating degradation of nuclear AID, any functional relevance of lysine modifications has remained elusive. METHODOLOGY/PRINCIPAL

findingsHere, we report functional implications of lysine modifications of the human AID protein by generating a panel of lysine to arginine mutants of AID and assessment of their catalytic class switch activity. We found that only mutation of Lys22 to Arg resulted in a significant reduction of class switching to IgG1 in transfected primary mouse B cells. This decrease in activity was neither reflected in reduced hypermutation of Ig genes in AID-mutant transfected DT40 B cell lines nor recapitulated in bacterial deamination assays, pointing to involvement of post-translational modification of Lys22 for AID activity in B cells. CONCLUSIONS/SIGNIFICANCE: Our results imply that lysine modification may represent a novel level of AID regulation and that Lys22 is important for effective AID activity.

Indexed as

Active Transport, Cell NucleusAICDA (Activation-Induced Cytidine Deaminase)AnimalsArginineCell LineCell NucleusChickensCytidine DeaminaseHumansImmunoglobulin Class SwitchingLysineMiceMutant ProteinsMutationSomatic Hypermutation, ImmunoglobulinStructure-Activity RelationshipAICDA (Activation-Induced Cytidine Deaminase)ArginineCytidine DeaminaseLysineMutant Proteins

Identifiers

PMID22363466
PMCPMC3282692
OpenAlexW2085852006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.